Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.

Biechlin ML, Bonmartin A, Gilly FN, Fraysse M, du Moulinet d'Hardemare A.

Nucl Med Biol. 2008 Aug;35(6):679-87. doi: 10.1016/j.nucmedbio.2008.05.009.

PMID:
18678353
2.

Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.

Verbeke K, Kieffer D, Vanderheyden JL, Reutelingsperger C, Steinmetz N, Green A, Verbruggen A.

Nucl Med Biol. 2003 Oct;30(7):771-8.

PMID:
14499336
3.

Lys and Arg in UBI: a specific site for a stable Tc-99m complex?

Meléndez-Alafort L, Ramírez Fde M, Ferro-Flores G, Arteaga de Murphy C, Pedraza-López M, Hnatowich DJ.

Nucl Med Biol. 2003 Aug;30(6):605-15.

PMID:
12900286
4.

Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis.

Blankenberg FG, Vanderheyden JL, Strauss HW, Tait JF.

Nat Protoc. 2006;1(1):108-10.

PMID:
17406220
5.

Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.

Broekema M, van Eerd JJ, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC, Harris TD.

J Med Chem. 2005 Oct 6;48(20):6442-53.

PMID:
16190770
6.

Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.

Gandomkar M, Najafi R, Shafiei M, Ebrahimi SE.

Appl Radiat Isot. 2007 Jul;65(7):805-8. Epub 2007 Mar 21.

PMID:
17467277
7.

Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.

Bruus-Jensen K, Poethko T, Schottelius M, Hauser A, Schwaiger M, Wester HJ.

Nucl Med Biol. 2006 Feb;33(2):173-83.

PMID:
16546671
8.

(99m)Tc-HYNIC-derivatized ternary ligand complexes for (99m)Tc-labeled polypeptides with low in vivo protein binding.

Ono M, Arano Y, Mukai T, Fujioka Y, Ogawa K, Uehara T, Saga T, Konishi J, Saji H.

Nucl Med Biol. 2001 Apr;28(3):215-24.

PMID:
11323230
9.

Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.

Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.

Chin Med J (Engl). 2012 Jul;125(14):2538-42.

PMID:
22882936
10.

Preclinical Validation of 99mTc-Annexin A5-128 in Experimental Autoimmune Myocarditis and Infective Endocarditis: Comparison with 99mTc-HYNIC-Annexin A5.

Benali K, Louedec L, Azzouna RB, Merceron O, Nassar P, Al Shoukr F, Petiet A, Barbato D, Michel JB, Sarda-Mantel L, Le Guludec D, Rouzet F.

Mol Imaging. 2015 Jan-Mar;14(1):7290201400049. doi: 10.2310/7290.2014.00049.

PMID:
28654391
11.

Preliminary biological evaluation of novel (99m)Tc-Cys-annexin A5 as a apoptosis imaging agent.

Lu C, Jiang Q, Hu M, Tan C, Ji Y, Yu H, Hua Z.

Molecules. 2013 Jun 10;18(6):6908-18. doi: 10.3390/molecules18066908.

12.

Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.

Vanderheyden JL, Liu G, He J, Patel B, Tait JF, Hnatowich DJ.

Nucl Med Biol. 2006 Jan;33(1):135-44.

PMID:
16459269
13.

Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.

Fonge H, de Saint Hubert M, Vunckx K, Rattat D, Nuyts J, Bormans G, Ni Y, Reutelingsperger C, Verbruggen A.

Bioorg Med Chem Lett. 2008 Jul 1;18(13):3794-8. doi: 10.1016/j.bmcl.2008.05.044. Epub 2008 May 16.

PMID:
18524580
14.

Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.

Tavaré R, Torres Martin De Rosales R, Blower PJ, Mullen GE.

Bioconjug Chem. 2009 Nov;20(11):2071-81. doi: 10.1021/bc900160j.

PMID:
19874007
15.

Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide.

Liu G, Wescott C, Sato A, Wang Y, Liu N, Zhang YM, Rusckowski M, Hnatowich DJ.

Nucl Med Biol. 2002 Jan;29(1):107-13.

PMID:
11786281
16.

A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.

Surfraz MB, Biagini SC, Blower PJ.

Dalton Trans. 2008 Jun 14;(22):2920-2. doi: 10.1039/b805110k. Epub 2008 Apr 14.

PMID:
18493625
17.

N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.

Banerjee SR, Maresca KP, Stephenson KA, Valliant JF, Babich JW, Graham WA, Barzana M, Dong Q, Fischman AJ, Zubieta J.

Bioconjug Chem. 2005 Jul-Aug;16(4):885-902.

PMID:
16029030
18.

RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging.

Edwards DS, Liu S, Ziegler MC, Harris AR, Crocker AC, Heminway SJ, Barrett JA, Bridger GJ, Abrams MJ, Higgins JD 3rd.

Bioconjug Chem. 1999 Sep-Oct;10(5):884-91.

PMID:
10502357
19.

Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.

Surfraz MB, King R, Mather SJ, Biagini SC, Blower PJ.

J Med Chem. 2007 Mar 22;50(6):1418-22. Epub 2007 Feb 23.

PMID:
17315986
20.

Supplemental Content

Support Center